Medicover AB (publ) (0RPS.L)

SEK 215.5

(0.47%)

Total Liabilities Summary of Medicover AB (publ)

Medicover AB (publ)'s latest annual total liabilities in 2023 was 1.41 Billion EUR , up 6.97% from previous year.
Medicover AB (publ)'s latest quarterly total liabilities in 2024 Q2 was 1.5 Billion EUR , up 3.43% from previous quarter.
Medicover AB (publ) reported annual total liabilities of 1.32 Billion EUR in 2022, up 17.71% from previous year.
Medicover AB (publ) reported annual total liabilities of 1.12 Billion EUR in 2021, up 78.87% from previous year.
Medicover AB (publ) reported quarterly total liabilities of 1.5 Billion EUR for 2024 Q2, up 3.43% from previous quarter.
Medicover AB (publ) reported quarterly total liabilities of 1.34 Billion EUR for 2023 Q2, up 2.37% from previous quarter.

Annual Total Liabilities Chart of Medicover AB (publ) (2023 - 2014)

Historical Annual Total Liabilities of Medicover AB (publ) (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	1.41 Billion EUR	6.97%
2022	1.32 Billion EUR	17.71%
2021	1.12 Billion EUR	78.87%
2020	627.4 Million EUR	-4.91%
2019	659.8 Million EUR	129.66%
2018	287.3 Million EUR	43.79%
2017	199.8 Million EUR	-37.7%
2016	320.7 Million EUR	46.04%
2015	219.6 Million EUR	22.61%
2014	179.1 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	1.45 Billion EUR	3.09%
2024 Q2	1.5 Billion EUR	3.43%
2023 Q2	1.34 Billion EUR	2.37%
2023 FY	1.41 Billion EUR	6.97%
2023 Q4	1.41 Billion EUR	2.8%
2023 Q1	1.31 Billion EUR	-0.54%
2023 Q3	1.37 Billion EUR	2.2%
2022 Q1	1.24 Billion EUR	10.65%
2022 Q4	1.32 Billion EUR	3.85%
2022 Q3	1.27 Billion EUR	1.49%
2022 Q2	1.25 Billion EUR	0.93%
2022 FY	1.32 Billion EUR	17.71%
2021 Q1	648.6 Million EUR	3.38%
2021 Q4	1.12 Billion EUR	31.28%
2021 Q2	702.2 Million EUR	8.26%
2021 FY	1.12 Billion EUR	78.87%
2021 Q3	854.8 Million EUR	21.73%
2020 Q4	627.4 Million EUR	8.81%
2020 Q1	683 Million EUR	3.52%
2020 Q2	601.1 Million EUR	-11.99%
2020 Q3	576.6 Million EUR	-4.08%
2020 FY	627.4 Million EUR	-4.91%
2019 Q2	550.7 Million EUR	22.05%
2019 FY	659.8 Million EUR	129.66%
2019 Q4	659.8 Million EUR	18.8%
2019 Q3	555.4 Million EUR	0.85%
2019 Q1	451.2 Million EUR	57.05%
2018 Q1	205.8 Million EUR	3.0%
2018 Q4	287.3 Million EUR	3.12%
2018 Q3	278.6 Million EUR	30.68%
2018 Q2	213.2 Million EUR	3.6%
2018 FY	287.3 Million EUR	43.79%
2017 Q4	199.8 Million EUR	16.91%
2017 FY	199.8 Million EUR	-37.7%
2017 Q1	322.2 Million EUR	0.47%
2017 Q2	156.1 Million EUR	-51.55%
2017 Q3	170.9 Million EUR	9.48%
2016 Q1	- EUR	0.0%
2016 Q4	320.7 Million EUR	0.0%
2016 FY	320.7 Million EUR	46.04%
2015 FY	219.6 Million EUR	22.61%
2014 FY	179.1 Million EUR	0.0%

Peer Total Liabilities Comparison of Medicover AB (publ)

Name	Total Liabilities	Total Liabilities Difference
Xvivo Perfusion AB (publ)	250.56 Million SEK	-463.923%